Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers.
about
The links between insulin resistance, diabetes, and cancerInteractions between tumor cells and microenvironment in breast cancer: a new opportunity for targeted therapyMetformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation.Herbal extract SH003 suppresses tumor growth and metastasis of MDA-MB-231 breast cancer cells by inhibiting STAT3-IL-6 signaling.Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer.Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.Phenotypic switch in blood: effects of pro-inflammatory cytokines on breast cancer cell aggregation and adhesionAdult aortic valve interstitial cells have greater responses to toll-like receptor 4 stimulation.Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion currentMetformin inhibits the IL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis.In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumorsMetformin suppresses pancreatic tumor growth with inhibition of NFκB/STAT3 inflammatory signaling.The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenografts.Metformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions.Metformin selectively targets tumor-initiating cells in ErbB2-overexpressing breast cancer models.Transcriptomic analysis of pancreatic cancer cells in response to metformin and aspirin: an implication of synergy.Src/STAT3-dependent heme oxygenase-1 induction mediates chemoresistance of breast cancer cells to doxorubicin by promoting autophagy.Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193bMetformin Treatment for the Prevention and/or Treatment of Breast/Mammary TumorigenesisMorphoproteomics provides support for TGF-β pathway signaling in the osteoclastogenesis and immune dysregulation of osteolytic Langerhans cell histiocytosis.AMPK/mTOR-mediated inhibition of survivin partly contributes to metformin-induced apoptosis in human gastric cancer cellHigh Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial Cancer.Metformin combined with aspirin significantly inhibit pancreatic cancer cell growth in vitro and in vivo by suppressing anti-apoptotic proteins Mcl-1 and Bcl-2Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes.Tristetraprolin mediates the anti-proliferative effects of metformin in breast cancer cellsTargeting HCCR expression resensitizes gastric cancer cells to chemotherapy via down-regulating the activation of STAT3.Interaction between p53 and estradiol pathways in transcriptional responses to chemotherapeutics.Metformin induces a senescence-associated gene signature in breast cancer cells.STAT signaling in different breast cancer sub-types.Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells.Curcumin improves the therapeutic efficacy of Listeria(at)-Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1.Enhanced anti-tumor activity and cytotoxic effect on cancer stem cell population of metformin-butyrate compared with metformin HCl in breast cancer.Morphoproteomics and biomedical analytics confirm the mTORC2/Akt pathway as a resistance signature and activated ERK and STAT3 as concomitant prosurvival/antiapoptotic pathways in metastatic renal cell carcinoma (RCC) progressing on rapalogs: pathogGlucose promotes breast cancer aggression and reduces metformin efficacy.Metformin targets multiple signaling pathways in cancer.Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling.AMP-activated protein kinase and energy balance in breast cancer.Arctigenin inhibits STAT3 and exhibits anticancer potential in human triple-negative breast cancer therapyGenomic regulation of invasion by STAT3 in triple negative breast cancer.Metformin Suppresses Systemic Autoimmunity in Roquinsan/san Mice through Inhibiting B Cell Differentiation into Plasma Cells via Regulation of AMPK/mTOR/STAT3.
P2860
Q26852910-1A0CC3D4-3633-4E26-B4F3-9B73F53BEC6AQ27012888-34837C9C-9BCF-4EDD-855D-0DB474B96D2AQ33577449-AE7C0ED1-447F-4850-A748-0656E573E1E9Q33757639-2BED5CAF-CCDB-4C2F-8618-8598553B5C8FQ33866151-7275EF09-8A38-419B-9325-4A296FD8F37AQ34103963-4062607B-AAEC-42CB-BB54-86407C54BCA4Q34571490-CA8DB97B-26C9-41C2-B2F9-CBAC64C66FADQ34810618-BCEB500D-94F1-4190-831E-B73D34298FD1Q34957274-E1854701-78CF-41A9-B52A-AC7D5CC603C9Q35161856-61473745-262A-49B8-B56E-6CF79728068AQ35425337-33569AC5-C297-4627-802D-8235FB8ADE7DQ35439302-2EF36A32-1E16-4A63-BAE0-82C087B10F0EQ35666599-9C863A64-33DF-48C4-93CD-87FB8DC2278AQ35751116-BBC40E99-8AFB-44A0-9712-08938ADB07BCQ35835794-C43F1240-1B6E-472F-8B28-FEF25FC3C25EQ35979251-5CDDE27E-063B-4409-9DE7-D4F4BF23D326Q36016229-EAB18883-A782-4611-9339-C15F9984BEBCQ36062114-4C19648E-38DD-4A19-B6EC-ECDAE93E6C49Q36078840-7B7527DA-5F1D-404D-8F6A-DB540C86F9D3Q36196768-28E92065-06EA-47FA-85F1-1C347A4F73E7Q36214450-0EE6E821-FDE2-4AE2-8D03-547A4BDEAADEQ36257678-F20FF202-A0AB-417D-86F3-78CE0A2ECA95Q36356287-9A0EB0D6-05FE-4EB6-A4BE-F78B141A04EFQ36560528-D23C759A-A5F9-4D13-A953-DA0889EDF5DFQ36678490-9E48413B-443D-4D8F-A7C2-28B572271D32Q36774158-3446753B-E5FC-481A-ABB8-F53C6405AED3Q36906240-6F058EAF-B5DB-4475-A53C-72A16309C4E3Q36922465-09E3C450-1D86-4823-A81B-62200F4BD726Q37086768-3BD87F40-49BF-40DA-BF9E-3A689F92A0C8Q37214346-378A9D46-254C-41D9-8D44-C15B860466C1Q37236288-A284568B-5FDA-418D-B3C5-3891855EFE89Q37437550-73D527B0-4167-4CA2-99E9-1C8DD7381E0FQ37520310-1D43EB67-81BA-4854-BEC9-8306EBB656D5Q37525828-90A9EA65-D437-4735-AD02-3998FBE04F12Q37609790-803C74DA-DA31-4B5A-9EDB-79EC23C6FDD1Q37620713-3465E63F-2F72-4493-81CC-F53985B62E3EQ37685196-11D423AB-417D-4769-8B08-40303E414588Q37702227-5C3FB5A0-56A4-45D7-8CE6-47576C551D28Q37702690-2F960F04-7BF2-421C-B7BA-739E9602EE41Q37710586-582E37A5-1C90-466C-8DD3-3301ABEFF7FE
P2860
Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Metformin targets Stat3 to inh ...... riple-negative breast cancers.
@en
Metformin targets Stat3 to inh ...... riple-negative breast cancers.
@nl
type
label
Metformin targets Stat3 to inh ...... riple-negative breast cancers.
@en
Metformin targets Stat3 to inh ...... riple-negative breast cancers.
@nl
prefLabel
Metformin targets Stat3 to inh ...... riple-negative breast cancers.
@en
Metformin targets Stat3 to inh ...... riple-negative breast cancers.
@nl
P2093
P356
P1433
P1476
Metformin targets Stat3 to inh ...... riple-negative breast cancers.
@en
P2093
Anlong Deng
Ann D Thor
Reema Wahdan-Alaswad
Shuiliang Wang
Stuart E Lind
Susan M Edgerton
Xin-Sheng Deng
P304
P356
10.4161/CC.11.2.18813
P577
2012-01-15T00:00:00Z